Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone

International Journal of Obesity

Volumn 21, Issue 5, 1997, Pages 355-359

  Nam, S Y ^a,b   Lee, E J ^a   Kim, K R ^a   Cha, B S ^a   Song, Y D ^a   Lim, S K ^a   Lee, H C ^a   Huh, K B ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Free IGF 1; IGFBPs; Obesity; Total IGF 1

Indexed keywords

GROWTH HORMONE; INSULIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN;

ADULT; AGE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; OBESITY; OVERNUTRITION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS;

EID: 0030993358     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800412     Document Type: Article

References (35)

1. Barbarino A, De Marinis L, Troncone L. Growth hormone response to propranolol and L-dopa in obese subjects. Metabolism 1978; 27: 275-278.
2. William T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med 1984; 311: 1403-1407.
3. Lee EJ, Kim KR, Lee KM, Lim SK, Lee HC, Lee JH, Lee DJ, Huh KB. Reduced growth hormone response to L-dopa and pyridostigmine in obesity. Int J Obes 1984; 18: 465-468.
4. Lee EJ, Nam SY, Kim KR, Lee HC, Cho JH, Nam MS, Song YD, Lim SK, Huh KB. Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects. J Clin Endocrinol Metab 1995; 80: 2495-2498.
5. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP. Impaired growth hormone secretion in the population: Relation to age and adiposity. J Clin Invest 1981; 67: 1361-1369.
6. Copeland KC, Colletti RB, Devlin JT, McAuliffe TL. The relationship between insulin-like growth factor-1, adiposity, and aging. Metabolism 1990; 39: 584-587.
7. Minuto F, Barreca A, Del Monte P, Fortini P, Resentini M, Morabito F. Spontaneous growth hormone and somatomedin-C/insulin-like growth factor-1 secretion in obese subjects during puberty. J Endocrinol Invest 1988; 11: 489-495.
8. Lamson G, Giudice LC, Rosenfeld RG. Insulin-like growth factor binding proteins: structural and molecular relationship. Growth Factor 1991; 5: 19-28.
9. Baxter WF, Martin JL. Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex. J Clin Endocrinol Metab 1988; 67: 265-272.
10. Mohan S, Baylink DJ (Editorial). Insulin-like growth factor (IGF)-binding proteins in serum - Do they have additional roles besides modulating the endocrine IGF actions? J Clin Endocrinol Metab 1996; 81: 3817-3820.
11. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR. A specific radioimmunoassay for growth hormone (GH)-dependent somatomedin binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990; 70: 1292-1298.
12. Smith WJ, Nam TJ, Underwood LE, Busby WH, Celnicker A, Clemmons DR. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-1 for assessing growth hormone status in short children. J Clin Endocrinol Metab 1993; 77: 1294-1299.
13. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor binding proteins. J Clin Endocrinol Metab 1988; 66: 266-272.
14. Holly JM, Biddlecombe RA, Dunger DB, Edge JA, Amiel SA, Howell R, Chard T, Rees LH, Wass JA. Circardian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin Endocrinol (Oxford) 1988; 29: 667-675.
15. Busby WH, Snyder DK, Clemmons DR. Radioimmunoassay of a 26,000-dalton plasm an insulin-like growth factor binding protein: control by nutritional factors. J Clin Endocrinol Metab 1988; 67: 1225-1230.
16. Baxter RC, Cowell CT. Diurnal variation rhythm of growth hormone independent binding protein for insulin-like growth factors in human plasma. J Clin Endocrinol Metab 1987; 65: 432-440.
17. Conover CA, Lee PD, Kanaley JA, Clarkson JT, Jensen MD. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab 1992; 74: 1355-1360.
18. Miell JP, Taylor AM, Jones J, Holly JM, Gaillard RC, Pralong FP, Ross RJ, Blum WF. The effect of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers. J Endocrinol 1993; 136: 525-533.
19. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16: 3-34.
20. Lee PDK, Powell DR, Baker B, Liu F, Belsha CW, Brewer ED, Hintz RL. Characterization of a direct non-extraction immunoradiometric assay for free IGF-1 (Abstract 939). Proceedings of the 76th Annual Meeting of the Endocrine Society 1994.
21. Caufriez A, Golstein J, Lebrun P, Herchuelz A, Fulanetto R, Copinschi G. Relation between immunoreactive somatomedin-C, insulin, and T3 patterns during fasting in obese subjects. Clin Endocrinol 1984; 20: 65-70.
22. Phillips L, Unterman T. Somatomedin activity in disorder of nutrition and metabolism. Clin Endocrinol Metab 1984; 13: 145-189.
23. Gryzwa M. Serum somatomedin activity and growth-hormone level in obese men: Dependence on degree of obesity and hyperlipidemia. Exp Clin Endocrinol 1986; 88: 325-330.
24. Soliman A, Hassan A, Aref M, Hintz R, Rosenfeld R, Rogol A. Serum IGF-I and IGF-II concentrations and growth hormone and insulin responses to arginine infusion in children with protein energy malnutrition before and after nutritional rehabilitation. Pediatr Res 1986; 20: 1122-1130.
25. Clemmons DR, Klibanski A, Underwood LE, McArthur JW, Ridgway EC, Betins IZ, Van Wyk JJ. Reduction of plasma immunoreactive somatomedin-C during fasting in humans. J Clin Endocrinol Metab 1981; 53: 1247-1251.
26. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and athersclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
27. Froesch ER, Guler HP, Schmid C, Zapf J. Therapeutic potential of insulin-like growth factor 1. Trends Endocrinol Metab 1990; 1: 254-260.
28. Cascieri MA, Seperatcin R, Hayes NS, Green BG, Chicchi GG, Applebaum J, Bayne ML. Serum half-life and biological activity of human insulin-like growth factor I which do not bind to serum binding proteins. Endocrinology 1988; 123: 373-381.
29. Lewitt MS. Role of the insulin-like growth factors in the endocrine control of glucose homeostasis. Diabetes Res Clin Pract 1994; 23: 3-15.
30. Frystyk J, Vestbo E, Skjærbæk C, Mogensen CE, Ørskov H. Free insulin-like growth factors in human obesity. Metabolism 1995; 44: 37-44.
31. Binoux M, Lalou C, Lasarre C, Blat C, Hossenlopp P. Limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3): a physiological mechanism in the regulation of IGF bioavailability. Current directions in insulin-like growth factor research. Plenum Press: New York. 1994 pp 293-300.
32. Bereket A, Wilson TA, Blethen SL, Fan J, Frost RA, Gelato MC, Lang CH. Effect of short-term fasting on free/dissociable insulin-like growth factor 1 concentrations in normal human serum. J Clin Endocrinol Metab 1996; 81: 4379-4384.
33. Brismar K, Fernqvist-Forbes E, Wahren J, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor binding protein (IGFBP)-I, IGFBP-3 and IGF-I in insulin dependent diabetes. J Clin Endocrinol Metab 1994; 79: 872-878.
34. Clemmons DR, Snyder DK, Busby WH. Variable controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. J Clin Endocrinol Metab 1991; 73: 727-233.
35. Young SCJ, Smith-Banks A, Underwood LE, Clemmons DR. Effects of recombinant IGF-1 and GH treatment upon serum IGF binding proteins in calorically restricted adults. J Clin Endocrinol Metab 1992; 75: 603-608.